SARCOMA

Latest News

Promising Efficacy for Tigilanol Tiglate in Advanced Soft Tissue Sarcoma
Promising Efficacy for Tigilanol Tiglate in Advanced Soft Tissue Sarcoma

July 1st 2025

A phase 2a trial shows tigilanol tiglate achieves an 80% response rate in soft tissue sarcoma, offering hope for effective treatment options.

Peers Weigh Efficacy vs Toxicity of Nirogacestat in Progressive Desmoid Tumors
Peers Weigh Efficacy vs Toxicity of Nirogacestat in Progressive Desmoid Tumors

June 16th 2025

EFTISARC-NEO Trial Meets Primary End Point in Soft Tissue Sarcoma
EFTISARC-NEO Trial Meets Primary End Point in Soft Tissue Sarcoma

May 28th 2025

THE001, Novel Sarcoma Treatment, Earns FDA Orphan Drug Designation
THE001, Novel Sarcoma Treatment, Earns FDA Orphan Drug Designation

May 12th 2025

Maintenance Regorafenib in Advanced Soft-Tissue Sarcoma Delays Progression
Maintenance Regorafenib in Advanced Soft-Tissue Sarcoma Delays Progression

April 28th 2025

More News